Aurinia Has FDA OK For Phase III Voclosporin Trialing In Lupus Nephritis

Following consultations with the FDA, Canada's Aurinia Pharmaceuticals plans to run a single Phase III trial for voclosporin in lupus nephritis and then proceed to filing an NDA.